News on digital experience in Pharma industry | News | Pharma Tech Outlook News pgno= 1
pharmatechoutlook
Home » News

Pharma Tech Outlook: Pharma Tech Magazine

Industry News

Key Services Offered by a CRO

Friday, February 26,2021

How Outsourcing R&D Processes to CROs Can Enhance Efficiency

How Outsourcing R&D Processes to CROs Can Enhance Efficiency

Thursday, February 25,2021

What are the Benefits of Using Quality Management System Software

What are the Benefits of Using Quality Management System...

Thursday, February 25,2021

Veeva OpenData Helps Leading Pharma Companies Deliver Accurate Data Faster

Veeva OpenData Helps Leading Pharma Companies Deliver...

Thursday, February 25,2021

Product Launch
AI-Enabled Digital Scanner for Actionable Insights
Powered by AI and ML, Supply Chain Frontlines Efficiency
Collateral Analytics Unveils Commercial AVM to Improve Monitoring of Property Values
Corporate News

Arctoris Unveils Ulysses, Next-Generation Robotic Platform

Wednesday, February 24,2021

Almirall and MC2 Therapeutics Announce Collaboration

Wednesday, February 24,2021

CloudLIMS and Folio Partner to Secure COVID-19 Results to Patients

Wednesday, February 24,2021

Salipro Biotech Given European Patent for Direct Extraction of Membrane Proteins from Cells

Wednesday, February 24,2021

Biomunex Pharmaceuticals Signs Strategic License and Co-Development Agreement with Onward...

Wednesday, February 24,2021

RxSources Improves the Clinical Labeling Procedure

Tuesday, February 16,2021

Featured Press Releases

NovAliX partners with Chemical.AI to develop artificial intelligence toolkit for drug discovery

Wednesday, January 27,2021

Accure Therapeutics appoints Dr. Rossella Medori as chief medical officer

Wednesday, January 27,2021

ENPICOM and MiLaboratories join forces to power better Repertoire Sequencing data management and analysis workflows

Monday, December 14,2020

Synthetic Biology continues to fight the battle against COVID-19

Friday, December 11,2020

Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development

Friday, December 04,2020

Glycostem initiates phase I/IIa (pivotal) trial to evaluate the safety and efficacy of oNKord® in patients with Acute Myeloid Leukemia (AML)

Tuesday, November 24,2020